Metabolic Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Metabolic Testing Market is segmented by Product Type (Body Composition Analyzers, Cardiopulmonary Exercise Testing (CPET) Systems, ECG Systems, Metabolic Carts, Others), Application, End User and Geography.

Market Snapshot

Metabolic Testing Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %
Metabolic Testing Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Metabolic rates may differ in people and depend upon gender, height, weight, age, muscle to fat ratios, and the current physical activity. The metabolism is divided into two types and can be divided into two categories catabolism which is the breakdown of food to obtain energy and anabolism which uses the energy produced by catabolic reactions to synthesize larger molecules from smaller ones like amino acids from proteins. catabolism and anabolism sets of reactions are critical to maintaining life. 

According to the World Health Organization (WHO), over 650 million adults were obese, 41 million children under the age of 5 were obese. According to the Global Burden of Disease study, about 4.7 million people died prematurely as a result of obesity. Therefore the increasing prevalence of lifestyle diseases such as cardiovascular disease, obesity, diabetes, technological advancements, and healthcare expenditure are the key driving factors in the metabolic testing market.

Scope of the Report

As per the scope of the report, metabolism is a chemical reaction that takes place in a living system, like in a cell, a tissue, an organ, or an organism that provides energy for vital processes and synthesis of new organic material.

By Equipment Type
Body Composition Analyzers
Cardiopulmonary Exercise Testing (CPET) Systems
ECG Systems
Metabolic Carts
By Application
Critical Care
Lifestyle Diseases
By End User
Hospitals and Clinics
Sports Training Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Lifestyle Diseases Segment is Expected to Hold a Major Market Share in the Metabolic Testing Market

The lifestyle diseases segment holds a major market share and is expected to grow significantly over the forecast period. Lifestyle diseases like atherosclerosis, heart disease, obesity, and type 2 diabetes and diseases associated with smoking and alcohol consumption. Factors like lifestyle and dietary patterns have clear and distinguishable effects on cardiometabolic disease and other metabolic disorders. 

According to the World Health Organization (WHO), at least 2.8 million individuals are dying each year as a result of being obese, and there are approximately 17 million deaths annually due to cardiovascular diseases. Hence, the rising prevalence of lifestyle diseases such as cardiovascular diseases, diabetes, and obesity are the key driving factors for the studied market.

Metabolic Testing Market Trends

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global metabolic testing market due to a rise in the prevalence of lifestyle diseases such as cardiovascular diseases, obesity, and type 2 diabetes in this region. According to the American Diabetes Association (ADA), in 2018, around 34.2 million Americans, or 10.5% of the population, had diabetes. Moreover, the rise in the adoption of advanced technologies in the metabolic testing market and the presence of well-established healthcare facilities is fueling the growth of the overall regional market to a large extent.

Metabolic Testing Market Growth

Competitive Landscape

The Metabolic Testing Market is moderately fragmented, competitive and consists of several market players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are MGC Diagnostics Corporation, COSMED Srl, CORTEX Biophysik GmbH, General Electric Company, KORR Medical Technologies, Inc, CareFusion Corporation, Geratherm Medical AG, OSI Systems, Inc, AEI Technologies, Inc, Parvo Medics.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Lifestyle Diseases

      2. 4.2.2 Technological Advancements in Metabolic Testing

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Equipment and Software

      2. 4.3.2 Poor Reimbursement Policies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Equipment Type

      1. 5.1.1 Body Composition Analyzers

      2. 5.1.2 Cardiopulmonary Exercise Testing (CPET) Systems

      3. 5.1.3 ECG Systems

      4. 5.1.4 Metabolic Carts

      5. 5.1.5 Others

    2. 5.2 By Application

      1. 5.2.1 Critical Care

      2. 5.2.2 Lifestyle Diseases

    3. 5.3 By End User

      1. 5.3.1 Hospitals and Clinics

      2. 5.3.2 Sports Training Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 MGC Diagnostics Corporation

      2. 6.1.2 COSMED srl

      3. 6.1.3 CORTEX Biophysik GmbH

      4. 6.1.4 GE Healthcare (General Electric Company)

      5. 6.1.5 KORR Medical Technologies, Inc

      6. 6.1.6 CareFusion Corporation

      7. 6.1.7 Geratherm Medical AG

      8. 6.1.8 OSI Systems, Inc

      9. 6.1.9 AEI Technologies, Inc

      10. 6.1.10 Parvo Medics

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Metabolic Testing Market market is studied from 2018 - 2026.

The Metabolic Testing Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

MGC Diagnostics Corporation, COSMED Srl, CORTEX Biophysik GmbH, GE Healthcare, KORR Medical Technologies, Inc are the major companies operating in Metabolic Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!